Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06455449
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2023-09-28
Brief Title:
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies Polymyositis and Dermatomyositis
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-28
First Submit QC Date:
June 11 2024
Study First Post Date:
2024-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-03
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED